DRS

SEC Filing Details

Document Details

Form
Filing Date
May 14, 2015
Document Date
May 14, 2015
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Nabriva Therapeutics
Issuer
NABRIVA THERAPEUTICS PLC